Table 1.
System | Type of measurement |
Insight about mechanism | Derived thermochemistry |
Reference(s) |
---|---|---|---|---|
Pro peptides (Pro-13, Pro-7, HisPro-13) | Equil, kinetics | PPI↔PPII; trans→cis isomerization; configurationally coupled proton transfer | ΔG, ΔH, ΔS: multiple intermediates; ΔG‡, ΔH‡, ΔS‡ for TS | 25, 64, 65 |
Peptides (bradykinin, Sub P) | Kinetics | Diketopiperazine formation; trans→cis isomerization; hidden intermediates | ΔG‡, ΔH‡, ΔS‡ for TS | 12, 13, 33, 55 |
Single-domain proteins (CI-2, Ub) | Equil, LASER heating (μs) | Two-state transition involving multiple native and denatured conformations | Tm for many states; ΔG, ΔH, ΔS, ΔCp, energy landscapes (CI-2) | 24, 27, 60 |
Multidomain protein complexes (Ub-dimer, Con A) | Equil | Complex dissociation; monomer subunits unfold independently (Ub); gradual structural change with increasing T (Con A) | Tm, ΔG, ΔH, ΔS, and ΔCp for many states | 23 |
Protein–ligand, metal cofactors (myoglobin, myo-hemerythrin, hemoglobin) | Equil, LASER heating (μs) | Loss of α-helical structure; loss of heme and oxygen; presence of partially unfolded state at μs timescales; formation of non-native disulfide bond; dioxidation modification | Tm for multiple states and processes; tetramer states | 76-78 |
Antibodies (IgG) | Kinetics | Light chain loss; non-native disulfide bond | ΔG‡, ΔH‡, ΔS‡ for loss of light chain | 8 |
Escherichia coli lysate | Equil | Complex mixture; complexes dissociate | Tm for many unknown complexes | 26 |
K-Ras and oncogenic mutants | Kinetics | Transition-state thermodynamics of the intrinsic GTPase activity | ΔG‡, ΔH‡, ΔS‡ for intrinsic GTPase activity | 53 |
Membrane protein–lipid and protein–protein interactions (AmtB, AmtB–GlnK) | Equil | Binding thermodynamics for membrane protein–lipid and membrane protein–soluble protein interactions | ΔG, ΔH, ΔS, and ΔCp | 14, 15 |
Abbreviations: CI-2, chemotrypsin inhibitor 2; IMS, ion mobility spectrometry; MS, mass spectrometry; TS, transition state.